Related Experiment Video
Updated: Aug 9, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Biocompatibility aspects of new stent technology
O F Bertrand1, R Sipehia, R Mongrain
1Research Center, Montreal Heart Institute, Division of Experimental Medicine, McGill University, Quebec, Canada. ofbert@icm.umontreal.ca
Journal of the American College of Cardiology
|September 19, 1998
Summary
Improving coronary angioplasty, this study reviews advancements in stent biocompatibility, focusing on preventing thrombus and neointima formation for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Science
- Interventional Cardiology
Background:
- Stent implantation is a key advancement in coronary angioplasty.
- Critical need to understand early and late biocompatibility of coronary stents.
- Challenges include preventing thrombus formation and late neointima development.
Purpose of the Study:
- To review current and emerging strategies for improving coronary stent biocompatibility.
- To highlight advancements in materials, coatings, and therapeutic applications of stents.
Main Methods:
- Evaluation of different metals and stent designs in animal models and human patients.
- Investigation of polymer coatings for enhanced biocompatibility and drug delivery.
- Review of biodegradable stents and radioactive stents for localized radiation therapy.
Main Results:
- Various metallic stents and designs have been tested.
- Polymer coatings show promise for improved biocompatibility and drug delivery.
- Biodegradable and radioactive stents are under development with encouraging early results.
Conclusions:
- Continued research into stent materials and coatings is crucial.
- Emerging technologies like biodegradable and radioactive stents offer future potential.
- Collaborative efforts between scientists and clinicians will advance stent biocompatibility.
